Biomaterial Tester Market Share, Growth, Opportunities 2032
Biomaterial Tester Market Share, Growth, Opportunities 2032
Segments - Biomaterial Tester Market by Application (Cardiovascular, Orthopedic, Dental, Ophthalmology, and Others), End-user (Educational Institutes, Hospitals & Clinics, R&D Laboratories, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032
Upcoming
| Report ID :HC-6519
| 4.7 Rating
| 95 Reviews
| 241 Pages
| Format :
Report Description
Biomaterial Tester Market Outlook 2032
The global biomaterial tester market size was USD 3.68 Billion in 2023 and is projected to reach USD 5.9 Billion by 2032, expanding at a CAGR of 3.67% during 2024–2032. The market growth is attributed to the growing adoption of biomaterial tasters in various healthcare settings.
Rising adoption of 3D printing technology in the healthcare industry is resulting in the high utilization of biomaterials testers, thereby boosting the market. Biomaterial testers are vital for evaluating the mechanical strength, biocompatibility, and structural integrity of 3D-printed constructs, ensuring their suitability for clinical use. Moreover, the increasing focus on personalized medicine and regenerative therapies has spurred the demand for biomaterials tailored to individual patient needs.
-
According to the report published by the National Library of Medicine on January 31, 2022, the number of drugs with personalized indications for their use surged by 70% from 2015 to 2020.
Impact of Artificial Intelligence (AI) on the Biomaterial Tester Market
The emergence of artificial intelligence is likely to boost the biomaterial tester market. AI algorithms assist in the design and synthesis of novel biomaterials by predicting material properties, biocompatibility, and degradation kinetics. Moreover, AI-driven imaging technologies enhance the characterization of biomaterials at the molecular and cellular levels, providing detailed information about structure-function relationships.
Biomaterial Tester Market Dynamics
Major Drivers
Increasing prevalence of chronic diseases, such as cardiovascular disorders, orthopedic ailments, and cancer, is expected to drive the market in the coming years. Biomaterials help address the unmet needs of patients suffering from chronic illnesses. Moreover, the global aging population contributes to the increasing prevalence of chronic diseases, thereby boosting the demand for biomaterial testers.
-
According to the report published by the WHO on September 16, 2023, cardiovascular diseases are one of the key causes of death, claiming the lives of approximately 17.9 million individuals each year. This is followed by cancer, responsible for 9.3 million deaths annually, chronic respiratory diseases causing 4.1 million deaths, and diabetes contributing to 2.0 million deaths, which includes fatalities from kidney disease associated with diabetes.
Existing Restraints
High initial investment required for biomaterial testers hinders the market. The development of advanced biomaterial testing equipment requires substantial investments in research, technology, and manufacturing infrastructure. Moreover, the ongoing maintenance and calibration expenses associated with biomaterial testing equipment hamper the market.
Emerging Opportunities
Growing investment in research & development (R&D) of biomaterial tester technology by the healthcare industry is expected to create immense opportunities in the market. Research institutions, academic organizations, and private companies are focusing on developing novel biomaterials with enhanced properties and functionalities to address unmet medical needs. Moreover, the rising demand for biocompatible materials in the healthcare industry propels the market.
Scope of the Biomaterial Tester Market Report
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
|
Attributes |
Details |
|
Report Title |
Biomaterial Tester Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2023 |
|
Historic Data |
2017 -2022 |
|
Forecast Period |
2024–2032 |
|
Segmentation |
Application (Cardiovascular, Orthopedic, Dental, Ophthalmology, and Others) and End-user (Educational Institutes, Hospitals & Clinics, R&D Laboratories, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
ADMET, Inc; CellScale; Intertek Group plc; MTS Systems; Rheolution Inc; University of Birmingham Enterprise Ltd; and ZwickRoell |
Regional Outlook
In terms of region, the global biomaterial tester market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major market share in 2023, due to the robust healthcare infrastructure and the rising investments in R&D by the healthcare industry. This advanced healthcare system and strong regulatory framework facilitate the development and adoption of biomaterial testing technologies. Moreover, the region's focus on innovation and technological advancement further boosted the demand for advanced biomaterial testers across various applications, such as medical implants, tissue engineering, and drug delivery.
The market in Asia Pacific is projected to grow at a significant pace in the coming years, owing to the increasing investments in biomedical research. Countries such as China, India, and Japan are investing heavily in biomaterials and medical devices, due to the growing prevalence of chronic diseases and the aging population. Furthermore, government initiatives aimed at improving healthcare infrastructure and promoting indigenous medical technology are likely to boost the adoption of biomaterial testing equipment in the region.
Biomaterial Tester Market Segment Insights
Application Segment Analysis
Based on application, the biomaterial tester market is divided into cardiovascular, orthopedic, dental, ophthalmology, and others. The cardiovascular segment is expected to expand at a significant growth rate in the coming years, due to the increasing prevalence of cardiovascular diseases across the globe.
Biomaterial testers are necessary for evaluating the biocompatibility and hemocompatibility of cardiovascular biomaterials, ensuring their safety and efficacy for use in cardiac interventions. For instance, according to the report published by the Centers for Disease Control and Prevention on May 15, 2023, one person dies from cardiovascular disease every 33 seconds in the US. Moreover, the government initiatives aimed at reducing cardiovascular disease burden are expected to boost the segment.
End-user Segment Analysis
On the basis of end-user, the global market is segregated into educational institutes, hospitals & clinics, R&D laboratories, and others. The hospitals & clinics segment held a large market share in 2023, due to the increasing demand for biomaterials in medical applications. Hospitals, clinics, and other healthcare facilities heavily use biomaterials in medical implants, tissue engineering, and drug delivery systems. Furthermore, the stringent regulatory requirements mandating the testing and validation of biomaterials before clinical use have further propelled the adoption of biomaterial testers in healthcare settings.
The R&D laboratories segment is anticipated to expand at a substantial CAGR during the forecast period, owing to the growing demand for advanced testing equipment in R&D laboratories. These laboratories are involved in fundamental research, product development, and preclinical testing of biomaterials, requiring sophisticated testing equipment to assess material properties and performance. Additionally, the rising focus on personalized medicine and regenerative therapies is expected to boost the adoption of advanced biomaterial testers.
Segments
The biomaterial tester market has been segmented on the basis of
Application
- Cardiovascular
- Orthopedic
- Dental
- Ophthalmology
- Others
End-user
- Educational Institutes
- Hospitals & Clinics
- R&D Laboratories
- Other
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- ADMET, Inc
- CellScale
- Intertek Group plc
- MTS Systems
- Rheolution Inc
- University of Birmingham Enterprise Ltd
- ZwickRoell
Competitive Landscape
Key players competing in the global biomaterial tester market are ADMET, Inc; CellScale; Intertek Group plc; MTS Systems; Rheolution Inc; University of Birmingham Enterprise Ltd; and ZwickRoell.
These companies use development strategies such as mergers, acquisitions, partnerships, collaboration, and product launches to expand their consumer base across the globe. For instance,
-
On September 18, 2023, the University of Birmingham Enterprise launched the BiMaTs. This service offers consultancy and comprehensive materials testing for dental and biomaterial manufacturers. BiMaTs operates under a unique commercialization model called an “Operating Division,” providing the industry with quick access to flexible, cutting-edge services rooted in Birmingham’s academic excellence.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Biomaterial Tester Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Biomaterial Tester Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Biomaterial Tester Market - Supply Chain
4.5. Global Biomaterial Tester Market Forecast
4.5.1. Biomaterial Tester Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Biomaterial Tester Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Biomaterial Tester Market Absolute $ Opportunity
5. Global Biomaterial Tester Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Biomaterial Tester Market Size and Volume Forecast by Applications
5.3.1. Cardiovascular
5.3.2. Orthopedic
5.3.3. Dental
5.3.4. Ophthalmology
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Biomaterial Tester Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Biomaterial Tester Market Size and Volume Forecast by End Users
6.3.1. Educational Institutes
6.3.2. Hospitals & Clinics
6.3.3. R&D Laboratories
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Biomaterial Tester Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Biomaterial Tester Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Biomaterial Tester Demand Share Forecast, 2019-2026
8. North America Biomaterial Tester Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Biomaterial Tester Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Biomaterial Tester Market Size and Volume Forecast by Applications
8.4.1. Cardiovascular
8.4.2. Orthopedic
8.4.3. Dental
8.4.4. Ophthalmology
8.4.5. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Biomaterial Tester Market Size and Volume Forecast by End Users
8.7.1. Educational Institutes
8.7.2. Hospitals & Clinics
8.7.3. R&D Laboratories
8.7.4. Other
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Biomaterial Tester Demand Share Forecast, 2019-2026
9. Latin America Biomaterial Tester Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Biomaterial Tester Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Biomaterial Tester Market Size and Volume Forecast by Applications
9.4.1. Cardiovascular
9.4.2. Orthopedic
9.4.3. Dental
9.4.4. Ophthalmology
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Biomaterial Tester Market Size and Volume Forecast by End Users
9.7.1. Educational Institutes
9.7.2. Hospitals & Clinics
9.7.3. R&D Laboratories
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Biomaterial Tester Demand Share Forecast, 2019-2026
10. Europe Biomaterial Tester Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Biomaterial Tester Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Biomaterial Tester Market Size and Volume Forecast by Applications
10.4.1. Cardiovascular
10.4.2. Orthopedic
10.4.3. Dental
10.4.4. Ophthalmology
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Biomaterial Tester Market Size and Volume Forecast by End Users
10.7.1. Educational Institutes
10.7.2. Hospitals & Clinics
10.7.3. R&D Laboratories
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Biomaterial Tester Demand Share Forecast, 2019-2026
11. Asia Pacific Biomaterial Tester Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Biomaterial Tester Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Biomaterial Tester Market Size and Volume Forecast by Applications
11.4.1. Cardiovascular
11.4.2. Orthopedic
11.4.3. Dental
11.4.4. Ophthalmology
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Biomaterial Tester Market Size and Volume Forecast by End Users
11.7.1. Educational Institutes
11.7.2. Hospitals & Clinics
11.7.3. R&D Laboratories
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Biomaterial Tester Demand Share Forecast, 2019-2026
12. Middle East & Africa Biomaterial Tester Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Biomaterial Tester Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Biomaterial Tester Market Size and Volume Forecast by Applications
12.4.1. Cardiovascular
12.4.2. Orthopedic
12.4.3. Dental
12.4.4. Ophthalmology
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Biomaterial Tester Market Size and Volume Forecast by End Users
12.7.1. Educational Institutes
12.7.2. Hospitals & Clinics
12.7.3. R&D Laboratories
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Biomaterial Tester Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Biomaterial Tester Market: Market Share Analysis
13.2. Biomaterial Tester Distributors and Customers
13.3. Biomaterial Tester Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. ADMET, Inc
13.4.2. CellScale
13.4.3. Intertek Group plc
13.4.4. MTS Systems
13.4.5. Rheolution Inc
13.4.6. University of Birmingham Enterprise Ltd
13.4.7. ZwickRoell
Methodology
Related Reports
Some other reports from this category!
Our Clients
